FIELD: medicine. SUBSTANCE: invention relates to the use of sodium salt of diethyl ester of 4-oxo-1,4-dihydropyrazolo[5,1-c]-1,2,4-triazine-3,8-dicarboxylic acid, monohydrate of the formula I as a drug for the treatment and prevention of long-term consequences of diabetes mellitus. Sodium salt of diethyl ester of 4-oxo-1,4-dihydropyrazolo[5,1-c]-1,2,4-triazine-3,8-dicarboxylic acid, monohydrate is an effective drug for the treatment and prevention of such diabetic complications as nephropathy, cardiomyopathy, neuropathy, encephalopathy, endothelial dysfunction and hemorheological disorders; it can be widely used in medicine in the field of therapy of late complications of diabetes mellitus. EFFECT: obtaining a drug for the treatment of complications of diabetes mellitus.
Translated title of the contributionUse of Sodium Salt of Diethyl Ester of 4-oxo-1,4-dihydropyrazolo[5,1-C]-1,2,4-triazine-3,8-dicarboxylic acid, Monohydrate as Drug for Treatment and Prevention of Late Complications of Diabetes Mellitus: patent of invention
Original languageRussian
Patent number2765117
IPCA61K 31/53,A61P 9/10,A61P 13/12,A61P 25/00,A61P 27/12,A61P 3/10,C07D 487/04
Priority date24/09/2019
Filing date24/09/2019
Publication statusPublished - 25 Jan 2022

    GRNTI

  • 76.03.00

ID: 30494783